| Literature DB >> 24882343 |
Melissa Pilewskie1, Monica Morrow2.
Abstract
This article reviews the relevant data on breast magnetic resonance imaging (MRI) use in screening, the short-term surgical outcomes and long-term cancer outcomes associated with the use of MRI in breast cancer staging, the use of MRI in occult primary breast cancer, as well as MRI to assess eligibility for accelerated partial breast irradiation and to evaluate tumor response after neoadjuvant chemotherapy. MRI for screening is supported in specific high-risk populations, namely, women with BRCA1 or BRCA2 mutations, a family history suggesting a hereditary breast cancer syndrome, or a history of chest wall radiation.Entities:
Keywords: Breast-conserving therapy; Local recurrence; Magnetic resonance imaging; Occult cancer; Screening
Mesh:
Year: 2014 PMID: 24882343 DOI: 10.1016/j.soc.2014.03.001
Source DB: PubMed Journal: Surg Oncol Clin N Am ISSN: 1055-3207 Impact factor: 3.495